Amantadine as a drug to mitigate the effects of COVID-19

Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41235

Registro completo de metadados

Campo DC	Valor	Idioma
dc.creator	Abreu, Gonzalo Emiliano Aranda	-
dc.creator	Aguilar, María Elena Hernández	-
dc.creator	Covarrubias, Deissy Herrera	-
dc.creator	Durán, Fausto Rojas	-
dc.date.accessioned	2020-05-26T15:48:37Z	-
dc.date.available	2020-05-26T15:48:37Z	-
dc.date.issued	2020-07	-
dc.identifier.citation	ABREU, G. E. A. et al. Amantadine as a drug to mitigate the effects of COVID-19. Medical Hypotheses, [S.l.], v. 140, July 2020.	pt_BR
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S030698772030654X	pt_BR
dc.identifier.uri	http://repositorio.ufla.br/jspui/handle/1/41235	-
dc.description.abstract	The SARS-CoV-2 virus has spread around the world. At this time, there is no vaccine that can help people prevent the spread of coronavirus. We are proposing amantadine as a drug that can be used to mitigate the effects of the virus. It is demonstrated by docking models how amantadine can exert its action on Coronavirus viroporin E.	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	restrictAccess	pt_BR
dc.source	Medical Hypotheses	pt_BR
dc.subject	COVID-19	pt_BR
dc.subject	Amantadine	pt_BR
dc.subject	Viroporin	pt_BR
dc.subject	Docking	pt_BR
dc.title	Amantadine as a drug to mitigate the effects of COVID-19	pt_BR
dc.type	Artigo	pt_BR
Aparece nas coleções:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:

Não existem arquivos associados a este item.